No recent analyst price targets found for EMMA.
Latest News for EMMA
Emmaus Life Sciences Reports Annual Financial Results
TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2025. Highlights “We experienced a 25% decline in net revenues in 2025 as compared to 2024 due to ongoing competition from generic…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EMMA.
U.S. House Trading
No House trades found for EMMA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.